Silencing of microRNAs in vivo with 'antagomirs'.
MicroRNAs (miRNAs) are an abundant class of non-coding RNAs that are believed to be important in many biological processes through regulation of gene expression. The precise molecular function of miRNAs in mammals is largely unknown and a better understanding will require loss-of-function studies in vivo. Here we show that a novel class of chemically engineered oligonucleotides, termed 'antagomirs', are efficient and specific silencers of endogenous miRNAs in mice. Intravenous administration of antagomirs against miR-16, miR-122, miR-192 and miR-194 resulted in a marked reduction of corresponding miRNA levels in liver, lung, kidney, heart, intestine, fat, skin, bone marrow, muscle, ovaries and adrenals. The silencing of endogenous miRNAs by this novel method is specific, efficient and long-lasting. The biological significance of silencing miRNAs with the use of antagomirs was studied for miR-122, an abundant liver-specific miRNA. Gene expression and bioinformatic analysis of messenger RNA from antagomir-treated animals revealed that the 3' untranslated regions of upregulated genes are strongly enriched in miR-122 recognition motifs, whereas downregulated genes are depleted in these motifs. Analysis of the functional annotation of downregulated genes specifically predicted that cholesterol biosynthesis genes would be affected by miR-122, and plasma cholesterol measurements showed reduced levels in antagomir-122-treated mice. Our findings show that antagomirs are powerful tools to silence specific miRNAs in vivo and may represent a therapeutic strategy for silencing miRNAs in disease.
Krützfeldt
Jan
J
Laboratory of Metabolic Diseases, The Rockefeller University, 1230 York Avenue, New York, New York 10021, USA.
Rajewsky
Nikolaus
N
Braich
Ravi
R
Rajeev
Kallanthottathil G
KG
Tuschl
Thomas
T
Manoharan
Muthiah
M
Stoffel
Markus
M
D020413:3' Untranslated Regions / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000070416:Antagomirs; D002784:Cholesterol / Q000096:biosynthesis / Q000378:metabolism; D019295:Computational Biology; D015536:Down-Regulation / Q000187:drug effects; D020868:Gene Silencing / Q000187:drug effects*; D051379:Mice; D035683:MicroRNAs / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D009841:Oligonucleotides / Q000378:metabolism*; D018075:RNA, Complementary / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D013379:Substrate Specificity; D013997:Time Factors; D015854:Up-Regulation / Q000187:drug effects
D020413:3' Untranslated Regions; D000070416:Antagomirs; D035683:MicroRNAs; D009841:Oligonucleotides; D018075:RNA, Complementary; C520440:antagomir-122; D002784:Cholesterol